{"schema_version":"1.0","type":"article","title":"印度製藥巨頭的野望！併購美國藥廠！","url":"https://drugnews.com.tw/articles/2026-05-02-sun-pharma-organon-acquisition.html","markdown_url":"https://drugnews.com.tw/articles/2026-05-02-sun-pharma-organon-acquisition.md","lang":"zh-Hant","date":"2026-05-02","publish_at":"2026-05-02T10:30:00+08:00","updated_at":"2026-05-02","category":"商業分析系列","topic":"商業分析系列","tags":["Dcard","免費文章","Sun Pharma","Organon","BD","Stelara"],"summary":"【Sun Pharma 117.5 億美元收購 Organon：印度學名藥巨頭「抄底」百年女性健康平台，全球藥廠版圖正在重新排位】📌 4 月 26 日，印度最大製藥公司 Sun Pharmaceuti","key_points":[],"facts":[],"sections":["01｜這筆交易買到的，不只是 Organon，而是一套全球商業化平台","02｜四個擴張維度：女性健康、成熟品牌藥、生物相似藥、創新藥占比","03｜為什麼印度學名藥巨頭現在要買？因為舊成長模型不夠用了","04｜這是一場「抄底」，但不是便宜貨遊戲","05｜Organon 為什麼願意賣？因為獨立平台需要新主人放大價值","06｜女性健康，可能是這筆交易最被低估的長線變數","07｜對印度製藥業來說，這是一個分水嶺","08｜但這筆交易也不是沒有風險"],"references":[{"title":"[0]:各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"Sun Pharma signs Definitive Agreement to Acquire Organon","source":"Organon","date":"","url":""},{"title":"Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limit","source":"","date":"","url":""},{"title":"www.organon.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025","source":"Organon","date":"","url":""},{"title":"Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted earnings per share of $3.66 Full year 2025 Adjusted EBITDA of $1.91 bill","source":"","date":"","url":""},{"title":"www.organon.com","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"reuters.com","source":"","date":"","url":""},{"title":"https://www.reuters.com/business/healthcare-pharmaceuticals/sun-pharma-acquire-organon-1175-bln-all-cash-deal-2026-04-27/","source":"","date":"","url":"https://www.reuters.com/business/healthcare-pharmaceuticals/sun-pharma-acquire-organon-1175-bln-all-cash-deal-2026-04-27/"},{"title":"www.reuters.com","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"Close banner","source":"","date":"","url":""},{"title":"Wendy Young, an advisor at Google Ventures and former head of small-molecule drug discovery at Genentech, discusses the dearth of women’s health drug discovery programmes. Wendy Young, an advisor at Google Ventures and former head of small-molecule drug d","source":"","date":"","url":""},{"title":"www.nature.com","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：印度製藥巨頭的野望！併購美國藥廠！","url":"https://drugnews.com.tw/assets/articles/sun-pharma-organon-acquisition/dcard-01.webp"}],"cover_image":"https://drugnews.com.tw/assets/articles/sun-pharma-organon-acquisition/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-05-02）。印度製藥巨頭的野望！併購美國藥廠！。https://drugnews.com.tw/articles/2026-05-02-sun-pharma-organon-acquisition.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-05-02-sun-pharma-organon-acquisition-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}